IXC
Click for more information
4.29% 6.7¢ invex therapeutics ltd

for a $1b market potential and these guys will be patented...

  1. northcott
    150 Posts.
    lightbulb Created with Sketch. 8
    clock Created with Sketch.
    05/07/19
    08:49
    Post #: 39383803
    for a $1b market potential and these guys will be patented protection for many years before other generics are allowed.

    this is exactly the history of Mayne Pharma that repurposed standard Acne drugs into different formulations and even Aspirin into a cardio treatment drug. They are are 850m market cap company but at their peak we're double this and beyond.

    There is no reason why it couldn't be a $1++ company if the patents deliver and efficacy proven of their products.
    IXC Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.7¢ 		Change
-0.003(4.29%) 		Mkt cap ! $5.035M
Open High Low Value Volume
7.0¢ 7.0¢ 6.7¢ $9.727K 141.0K

Buyers (Bids)

No. Vol. Price($)
1 10000 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 37500 1
View Market Depth
Last trade - 13.44pm 27/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.